MX2020002216A - Metodos y composiciones para detectar y tratar endometriosis. - Google Patents
Metodos y composiciones para detectar y tratar endometriosis.Info
- Publication number
- MX2020002216A MX2020002216A MX2020002216A MX2020002216A MX2020002216A MX 2020002216 A MX2020002216 A MX 2020002216A MX 2020002216 A MX2020002216 A MX 2020002216A MX 2020002216 A MX2020002216 A MX 2020002216A MX 2020002216 A MX2020002216 A MX 2020002216A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- compositions
- detecting
- treating endometriosis
- endometriosis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
La presente descripción proporciona métodos mejorados para proporcionar la prueba de endometriosis a pacientes, así como métodos mejorados para supervisar y ajustar los tratamientos de endometriosis.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762552365P | 2017-08-30 | 2017-08-30 | |
PCT/US2018/048649 WO2019046494A1 (en) | 2017-08-30 | 2018-08-29 | METHODS AND COMPOSITIONS FOR DETECTION AND TREATMENT OF ENDOMETRIOSIS |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020002216A true MX2020002216A (es) | 2020-08-20 |
Family
ID=65526037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020002216A MX2020002216A (es) | 2017-08-30 | 2018-08-29 | Metodos y composiciones para detectar y tratar endometriosis. |
Country Status (10)
Country | Link |
---|---|
US (2) | US20200206303A1 (es) |
EP (1) | EP3676395A4 (es) |
JP (1) | JP2020532305A (es) |
KR (1) | KR20200049824A (es) |
CN (1) | CN111295453A (es) |
AU (1) | AU2018324040A1 (es) |
CA (1) | CA3073829A1 (es) |
IL (1) | IL272570A (es) |
MX (1) | MX2020002216A (es) |
WO (1) | WO2019046494A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3122905B1 (en) | 2014-03-27 | 2020-09-09 | Yale University | Circulating micrornas as biomarkers for endometriosis |
EP3442706A4 (en) | 2016-04-13 | 2020-02-19 | NextGen Jane, Inc. | SAMPLE COLLECTION AND PRESERVATION DEVICES, SYSTEMS AND METHODS |
WO2018044979A1 (en) | 2016-08-30 | 2018-03-08 | Yale University | Micrornas as biomarkers for endometriosis |
US11315660B2 (en) | 2018-10-31 | 2022-04-26 | Dot Laboratories, Inc. | Method of detecting and treating endometriosis in a female subject |
BR112021021866A2 (pt) * | 2019-04-29 | 2021-12-21 | Dot Laboraties Inc | Classificadores para a detecção de endometriose |
CN115066207A (zh) * | 2019-11-01 | 2022-09-16 | 新生代吉恩公司 | 用于月经组分析的方法和系统 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR065584A1 (es) * | 2007-03-01 | 2009-06-17 | Cryo Cell Internat Inc | Obtencion aislamiento y crioconservacion de celulas endometriales / menstruales |
WO2009143181A2 (en) * | 2008-05-19 | 2009-11-26 | The Regents Of The University Of California | Micro-rna profile in human saliva and its use for detection of oral cancer |
GB201403489D0 (en) * | 2014-02-27 | 2014-04-16 | Univ London Queen Mary | Biomarkers for endometriosis |
US9650676B2 (en) * | 2014-03-19 | 2017-05-16 | University Of South Carolina | Leukocyte MicroRNAS for use in diagnosis and treatment of endometriosis |
EP3122905B1 (en) * | 2014-03-27 | 2020-09-09 | Yale University | Circulating micrornas as biomarkers for endometriosis |
WO2016014683A1 (en) * | 2014-07-23 | 2016-01-28 | John Tomasko | In-line pressure relief valve and rupture disk |
WO2018044979A1 (en) * | 2016-08-30 | 2018-03-08 | Yale University | Micrornas as biomarkers for endometriosis |
-
2018
- 2018-08-29 CN CN201880071316.6A patent/CN111295453A/zh active Pending
- 2018-08-29 CA CA3073829A patent/CA3073829A1/en not_active Abandoned
- 2018-08-29 WO PCT/US2018/048649 patent/WO2019046494A1/en unknown
- 2018-08-29 EP EP18852025.8A patent/EP3676395A4/en not_active Withdrawn
- 2018-08-29 AU AU2018324040A patent/AU2018324040A1/en not_active Abandoned
- 2018-08-29 JP JP2020512837A patent/JP2020532305A/ja active Pending
- 2018-08-29 MX MX2020002216A patent/MX2020002216A/es unknown
- 2018-08-29 KR KR1020207009241A patent/KR20200049824A/ko not_active Application Discontinuation
-
2020
- 2020-02-10 IL IL272570A patent/IL272570A/en unknown
- 2020-02-21 US US16/798,077 patent/US20200206303A1/en not_active Abandoned
-
2022
- 2022-06-07 US US17/834,762 patent/US20220305075A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20220305075A1 (en) | 2022-09-29 |
IL272570A (en) | 2020-03-31 |
AU2018324040A1 (en) | 2020-03-05 |
CN111295453A (zh) | 2020-06-16 |
US20200206303A1 (en) | 2020-07-02 |
JP2020532305A (ja) | 2020-11-12 |
KR20200049824A (ko) | 2020-05-08 |
EP3676395A4 (en) | 2021-09-01 |
EP3676395A1 (en) | 2020-07-08 |
WO2019046494A1 (en) | 2019-03-07 |
CA3073829A1 (en) | 2019-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020002216A (es) | Metodos y composiciones para detectar y tratar endometriosis. | |
MX2019003623A (es) | Composiciones y metodos para el tratamiento de afecciones oftalmicas. | |
MX2021014709A (es) | Composiciones para usarse en el incremento de los niveles de globulos rojos y el tratamiento de enfermedad de celulas falciformes. | |
MX2017013562A (es) | Reguladores de microbioma y usos relacionados de los mismos. | |
NZ720949A (en) | Methods and compositions for treating aging-associated conditions | |
MX2017010150A (es) | Bacterias probioticas recombinantes. | |
AU2016263598A8 (en) | Methods and kits for treating depression | |
NZ720769A (en) | Anti-siglec-8 antibodies and methods of use thereof | |
MX2018012493A (es) | Métodos para controlar y tratar el cáncer. | |
WO2016061509A8 (en) | Compositions and methods of treating muscular dystrophy | |
MX2015009276A (es) | Donadores de nitroxilo con indice terapeutico mejorado. | |
MX2018006700A (es) | Inhibidores aza-bencimidazol de peptidilarginina desiminasa (pad4). | |
PH12018501279A1 (en) | Compositions comprising 15-hepe and methods of using the same | |
WO2014205266A3 (en) | Compositions and methods for detecting and treating glioblastoma | |
MX2017000306A (es) | Metodos para tratar hipotension. | |
MX2017006019A (es) | Apilimod para uso en el tratamiento de melanoma. | |
MX367393B (es) | Composiciones antifungicas para el tratamiento de piel y uñas. | |
MX2018005987A (es) | Compuestos heterociclicos para el tratamiento de enfermedades. | |
MX2016009655A (es) | Metodos novedosos para el tratamiento del cancer. | |
MX2016007902A (es) | Composiciones y metodos para el tratamiento del glaucoma. | |
TR201900665T4 (tr) | Diyabetik nefropatinin tedavi yöntemi. | |
PH12019500479A1 (en) | Compositions for treating dementia | |
PH12016501434A1 (en) | Compositions for use in the treatment of allergic conditions | |
MX2021008225A (es) | Composiciones y metodos para tratamiento de crecimiento celular anormal. | |
IN2014CH00304A (es) |